The pressing need for imaging biomarkers of disability progression in multiple sclerosis

被引：1
作者：
Naval-Baudin, Pablo [1 ,2 ,3 ,4 ]
Arroyo-Pereiro, Pablo [4 ,5 ,6 ]
Majos, Carles [1 ,2 ,3 ]
机构：
[1] Hosp Univ Bellvitge, Radiol Dept, Carrer Feixa Llarga SN, Barcelona 08907, Spain
[2] Inst Diag Imatge IDI, Ctr Bellvitge,Carrer Feixa Llarga SN, Barcelona 08907, Spain
[3] Bellvitge Biomed Res Inst IDIBELL, Diag Imaging & Nucl Med Res Grp, Barcelona 08907, Spain
[4] Univ Barcelona UB, Dept Ciencies Clin, Fac Med & Ciencies Salut, Carrer Casanova 143, Barcelona 08036, Spain
[5] Hosp Univ Bellvitge, Dept Neurol, Multiple Sclerosis Unit, Carrer Feixa Llarga SN, Barcelona 08907, Spain
[6] Bellvitge Biomed Res Inst IDIBELL, Neurol Dis & Neurogenet Grp, Barcelona 08907, Spain
来源：
EUROPEAN RADIOLOGY | 2024年 / 34卷 / 06期
关键词：
MRI;
D O I：
10.1007/s00330-023-10459-9
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：3823 / 3825
页数：3
相关论文
共 50 条
[31]   Predictors of multiple sclerosis progression: A systematic review of conventional magnetic resonance imaging studies [J].
Lomer, Nima Broomand ;
Asalemi, Kamal AmirAshjei ;
Saberi, Alia ;
Sarlak, Kasra .
PLOS ONE, 2024, 19 (04)
[32]   Predicting the profile of increasing disability in multiple sclerosis [J].
Tomassini, Valentina ;
Fanelli, Fulvia ;
Prosperini, Luca ;
Cerqua, Raffaella ;
Cavalla, Paola ;
Pozzilli, Carlo .
MULTIPLE SCLEROSIS JOURNAL, 2019, 25 (09) :1306-1315
[33]   Diffusion Tensor Imaging of the Optic Nerve in Multiple Sclerosis: Association with Retinal Damage and Visual Disability [J].
Smith, S. A. ;
Williams, Z. R. ;
Ratchford, J. N. ;
Newsome, S. D. ;
Farrell, S. K. ;
Farrell, J. A. D. ;
Gifford, A. ;
Miller, N. R. ;
van Zijl, P. C. M. ;
Calabresi, P. A. ;
Reich, D. S. .
AMERICAN JOURNAL OF NEURORADIOLOGY, 2011, 32 (09) :1662-1668
[34]   Multiple sclerosis lesions on magnetic resonance imaging, their characterization and pathological correlation with musculoskeletal disability in Pakistanis [J].
Zaidi, Nasir Raza ;
Ahmad, Mian Waheed ;
Mehboob, Riffat .
ASIAN BIOMEDICINE, 2016, 10 (06) :567-574
[35]   How patients with multiple sclerosis acquire disability [J].
Lublin, Fred D. ;
Haering, Dieter A. ;
Ganjgahi, Habib ;
Ocampo, Alex ;
Hatami, Farhad ;
Cuklina, Jelena ;
Aarden, Piet ;
Dahlke, Frank ;
Arnold, Douglas L. ;
Wiendl, Heinz ;
Chitnis, Tanuja ;
Nichols, Thomas E. ;
Kieseier, Bernd C. ;
Bermel, Robert A. .
BRAIN, 2022, 145 (09) :3147-3161
[36]   Does Ocrelizumab Limit Multiple Sclerosis Progression? Current Evidence from Clinical, MRI, and Fluid Biomarkers [J].
Monica Margoni ;
Paolo Preziosa ;
Paola Tortorella ;
Massimo Filippi ;
Maria A. Rocca .
Neurotherapeutics, 2022, 19 :1216-1228
[37]   Does Ocrelizumab Limit Multiple Sclerosis Progression? Current Evidence from Clinical, MRI, and Fluid Biomarkers [J].
Margoni, Monica ;
Preziosa, Paolo ;
Tortorella, Paola ;
Filippi, Massimo ;
Rocca, Maria A. .
NEUROTHERAPEUTICS, 2022, 19 (04) :1216-1228
[38]   Imaging Butyrylcholinesterase in Multiple Sclerosis [J].
Thorne, M. W. D. ;
Cash, M. K. ;
Reid, G. A. ;
Burley, D. E. ;
Luke, D. ;
Pottie, I. R. ;
Darvesh, S. .
MOLECULAR IMAGING AND BIOLOGY, 2021, 23 (01) :127-138
[39]   Monitoring of Lymphocyte Populations During Treatment with Interferon--1b to Predict Multiple Sclerosis Disability Progression [J].
Valis, Martin ;
Vysata, Oldrich ;
Sobisek, Lulas ;
Klimova, Blanka ;
Andrys, Ctirad ;
Vokurkova, Doris ;
Pavelek, Zbysek .
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2019, 39 (03) :164-173
[40]   Long-term disease activity and disability progression in relapsing-remitting multiple sclerosis patients on natalizumab [J].
Dekker, I ;
Leurs, C. E. ;
Hagens, M. H. J. ;
van Kempen, Z. L. E. ;
Kleerekooper, I ;
Lissenberg-Witte, B., I ;
Barkhof, F. ;
Uitdehaag, B. M. J. ;
Balk, L. J. ;
Wattjes, M. P. ;
Killestein, J. .
MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2019, 33 :82-87
12345